News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

How A Potential Drug And A Possible M&A Could Drive Exelixis (EXEL) Even Higher



8/28/2017 7:17:46 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.

But there were some investors who did something on that date who probably recall it with a smile. Anyone who bought shares of Exelixis at the beginning of 2015 and held on to the stock are now sitting on a return of 1,560%. A $10,000 investment in the biotech less than three years ago would now be worth $166,000.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES